Soy formula in infancy may up odds of later menstrual pain | Acupuncture in the ED reduces pain, stress, anxiety | FDA fast-tracks Vivozon pain candidate
November 14, 2018
News for the pain professional
SIGN UP ⋅   FORWARD
Pain Research News
Soy formula in infancy may up odds of later menstrual pain
Women who had ever received soy-based formula as infants had a 50% increased likelihood of having moderate or severe menstrual pain at ages 18 to 22 and a 40% higher risk of having used hormonal contraception for menstrual discomfort, compared with those who weren't fed soy formula in infancy, researchers reported in the journal Human Reproduction. The findings were based on data involving 1,553 African-American women ages 23 to 35.
United Press International (11/9),  The New York Times (tiered subscription model) (11/9) 
LinkedIn Twitter Facebook Email
Acupuncture in the ED reduces pain, stress, anxiety
Emergency department administration of acupuncture may provide pain relief and reduce patient stress and anxiety, according to a study presented at the Academy of Integrative Pain Management's Inaugural Global Pain Clinician Summit. In light of the current opioid crisis, "[a]nything we can do to reduce the initial onset of prescription opioids is a positive move," according to Dr. Clayton Jackson, palliative care physician and president of AIPM.
Medscape (free registration) (11/12) 
LinkedIn Twitter Facebook Email
Other News
Treatment News
Case report links maternal kratom use to withdrawal symptoms in infant
A case study in Pediatrics described a mother who drank kratom tea daily during gestation to treat her opioid dependence and whose male newborn developed opioid withdrawal symptoms, such as irritability, jitteriness and sneezing, at 33 hours after birth. The infant's condition improved after receiving a common blood pressure medication and morphine, and he was discharged on the eighth day of life.
HealthDay News (11/7) 
LinkedIn Twitter Facebook Email
Study data positive for Boston Scientific's Eluvia in long lesions
Data from a 50-patient, single-arm analysis of Boston Scientific's Eluvia drug-eluting vascular stent system show an 87.9% primary patency rate and a 6.5% target lesion revascularization rate in patients with femoropopliteal artery lesions ranging from 140 mm to 190 mm. Trial participants also reported improvements in leg pain and discomfort.
Drug Delivery Business News (11/6) 
LinkedIn Twitter Facebook Email
Other News
Policy & Trends
An oncologist struggles to support patient decisions about palliative care
Dr. Isaac Chan, a medical oncology fellow at Johns Hopkins Hospital, discusses observing a patient's difficulty in discontinuing chemotherapy and pursuing palliative care, even when it may offer pain relief and time with family. Respecting a patient's wishes is the top priority, he says, and "sometimes what our patients need most is just more time: time to accept the terminal diagnosis and time to grieve and hopefully find peace."
Next Avenue (11/13) 
LinkedIn Twitter Facebook Email
FDA challenge to curb opioid crisis draws more than 200 medtech applications
An innovation challenge launched by the FDA to address the opioid crisis through device-based treatments, mobile apps and diagnostic tests has received more than 200 applications from companies, including Stimwave, Abbott and SPR Therapeutics, hoping to see faster approval for their technologies. The FDA is pleased by "the acknowledgment from developers about the unique and important role medical devices, including digital health technologies like mobile medical apps, have the potential to play in tackling the opioid crisis," FDA Commissioner Scott Gottlieb said.
Reuters (11/9) 
LinkedIn Twitter Facebook Email
Other News
APS News
Give to the Pain Research Fund
The APS Pain Research Fund provides an outlet for the pain science community to donate funds to support research grants, directly supporting APS's mission to increase the knowledge of pain and transform public policy and clinical practice to reduce pain-related suffering. Make a contribution to the Pain Research Fund this #GivingTuesday to support the cause!
LinkedIn Twitter Facebook Email
Join Us for the 2019 APS Scientific Meeting
Come to the Scientific Meeting to connect with clinicians and find out what's happening in other institutions, hospital systems, and practices. With 60-minute cross-disciplinary panels or 30-minute presentations, this year's meeting offers a variety of formats to showcase the latest research and highlight the experts on the cutting-edge of practice. Register by Jan. 31, 2019, to save. Learn more.
LinkedIn Twitter Facebook Email
  
  
In mathematics, the art of asking questions is more valuable than solving problems.
Georg Cantor,
mathematician
LinkedIn Twitter Facebook Email
  
  
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Molly Ufheil
Editor  -  Nicole Brown
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information